Local treatment of vulvovaginal candidosis : general and practical considerations.

Drugs
José das NevesMaria F Bahia

Abstract

Vulvovaginal candidosis is a common worldwide female medical problem, occurring mostly in women of childbearing age. Currently available options for the treatment of this condition include local and oral (systemic) therapy. Both alternatives have been considered equally effective in the treatment of uncomplicated vulvovaginal candidosis, although oral regimens are often preferred by physicians and women. However, local treatment presents several advantageous and unique features that may favour this therapeutic approach. The availability of numerous antifungal drugs and products for topical administration makes the selection quite challenging as this task is mostly based on personal experience or anecdotal data. Also, recent advances have been made in topical antifungal formulations and there is an increasing availability of over-the-counter products. Therefore, a review of both general and practical considerations related to the local treatment of vulvovaginal candidosis is timely.In summary, azoles and short-term regimens are usually recommended for the local treatment of vulvovaginal candidosis, with nystatin and boric acid considered as second-line alternatives. Unconventional approaches may also be regarded as suitable in p...Continue Reading

References

May 20, 1995·Lancet·W B ShelleyE D Shelley
Jun 1, 1995·Obstetrics and Gynecology·A SpinilloG Piazzi
Apr 1, 1996·The British Journal of Dermatology·H HeikkiläS Reitamo
Jul 1, 1996·Clinical Microbiology Reviews·P L Fidel, J D Sobel
Oct 1, 1996·Journal of Clinical Microbiology·J D Sobel, W Chaim
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel, W Chaim
Dec 20, 1997·The New England Journal of Medicine·J D Sobel
Mar 21, 1998·American Journal of Obstetrics and Gynecology·J D SobelP R Summers
Oct 30, 1998·Obstetrics and Gynecology·L O EckertK K Holmes
Jan 9, 1999·Clinical Microbiology Reviews·D J SheehanC M Sibley
Jul 20, 1999·American Journal of Obstetrics and Gynecology·H C Wiesenfeld, I Macio
Aug 7, 1999·Journal of Applied Microbiology·K A HammerT V Riley
Jan 20, 2000·Infection and Immunity·P L FidelC Steele
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E Dismukes
Jul 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J D Sobel
Aug 5, 2000·Drugs & Aging·N C Nwokolo, F C Boag
Aug 15, 2000·American Journal of Obstetrics and Gynecology·A HelfgottB Van Eckhout
Feb 28, 2001·Sexually Transmitted Infections·P P WalkerE G Evans
Apr 6, 2001·Sexually Transmitted Diseases·T Rosen, H Hwong
Aug 3, 2001·American Journal of Obstetrics and Gynecology·M Dan
Aug 24, 2001·American Journal of Obstetrics and Gynecology·J M BaetenJ K Kreiss
Feb 15, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·Margaret C WatsonAnne Ludbrook
Feb 28, 2002·Obstetrics and Gynecology·Daron G FerrisMark S Litaker
Mar 7, 2002·Trends in Molecular Medicine·Walter MaglianiLuciano Polonelli
Mar 21, 2002·The Lancet Infectious Diseases·Dominique Sanglard, Frank C Odds
Jul 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jung Yun ChangChong-Kook Kim
Aug 14, 2002·Cellular Microbiology·Paula Sundstrom
Sep 3, 2002·The Journal of Antimicrobial Chemotherapy·David A StevensClaude P Selitrennikoff
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shivani SinghJose A Vazquez
Apr 17, 2003·The Medical Journal of Australia·Belinda M WelshChristopher K Fairley
Aug 28, 2003·Archives of Gynecology and Obstetrics·K FrieseJ Siebert
Aug 30, 2003·Expert Opinion on Drug Safety·Varsha V Moudgal, Jack D Sobel
Sep 11, 2003·Pharmacy World & Science : PWS·Margaret C WatsonUNKNOWN Grampian Evidence Based Community Pharmacy Guidelines Group
Nov 25, 2003·American Journal of Obstetrics and Gynecology·Jack D SobelDeborah Leaman
Dec 18, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·C Pina-VazJ Martinez-de-Oliveira
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
May 29, 2004·BMJ : British Medical Journal·Helen Mitchell
Jun 18, 2004·Current Medical Research and Opinion·Bruno MolteniMassimo Milani
Jun 24, 2004·Contact Dermatitis·Serena SestiniStefano Francalanci
Aug 19, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K BanerjeeJ C Graham

❮ Previous
Next ❯

Citations

Jul 3, 2009·The Journal of Antimicrobial Chemotherapy·Gloria M GonzálezMariana Elizondo
Feb 2, 2011·BMC Public Health·Isabel Del-Cura GonzálezUNKNOWN GRUPO PRESEVAC
Jul 22, 2011·Journal of Women's Health·Christos IavazzoMatthew E Falagas
Aug 13, 2013·Journal of Liposome Research·Željka VanićJelena Filipović-Grčić
May 10, 2013·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·A KalkanciS Kuştimur
Nov 15, 2011·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·A Palmeira-de-OliveiraJ A Queiroz
Oct 18, 2011·Journal of Infection and Public Health·Leila SekhavatFatemah Zare Tezerjani
Jan 20, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Beatrice AlbertiniLorenzo Rodriguez
Jan 1, 2015·Advanced Drug Delivery Reviews·José das NevesBruno Sarmento
Jun 15, 2014·International Journal of Pharmaceutics·May Wenche JøraholmenNataša Skalko-Basnet
Aug 3, 2012·The Journal of the American Dental Association·Mark Donaldson, Jason H Goodchild
Apr 3, 2013·Carbohydrate Polymers·M J Martín-VillenaB Clares-Naveros
Nov 6, 2012·Carbohydrate Polymers·A AbruzzoB Luppi
Aug 15, 2012·Gynecologic and Obstetric Investigation·A R Gomes-de-ElvasJ Martinez-de-Oliveira
Feb 3, 2021·Mycoses·Alex FarrWerner Mendling
Jul 20, 2021·Advanced Drug Delivery Reviews·José das NevesBruno Sarmento
Jun 23, 2020·Current Molecular Pharmacology·Sandeep Kaur, Sukhbir Kaur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Peter G PappasInfectious Diseases Society of America
The New England Journal of Medicine
L O Eckert
© 2022 Meta ULC. All rights reserved